Dermatology and therapy
Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial.
Michael T Brennan, Jennifer Frustino, Kamal Al-Eryani, Herve Sroussi, Jennifer L Parish, Hirak B Routh, Sunil Dhawan, Gerald L Klein, Michael B Chancellor, Alessandro Villa
Published: 202510.1007/s13555-025-01572-2
Abstract
INTRODUCTION: Oral lichen planus (OLP) is a serious chronic inflammatory condition with malignant transformation potential affecting six million Americans which has no US Food and Drug Administration (FDA)-approved therapy. LP-10, a novel liposomal t…
Preview only. Read the full abstract at the source